New bladder cancer treatment TAR-200 put to the test in everyday clinics

NCT ID NCT07309445

Recruiting now Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 4 times

Summary

This study is tracking 150 people with early-stage bladder cancer who are receiving TAR-200, a treatment placed directly into the bladder. Researchers want to see how long it takes for the cancer to come back or get worse in real-world settings, not just in controlled trials. The goal is to understand if TAR-200 works well outside of research hospitals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TAR-200 (a drug delivery system placed in the bladder to release chemotherapy locally)
What this could lead to: If successful, this study could show that TAR-200 is effective in everyday medical practice for delaying or preventing the return of early-stage bladder cancer.
What could go wrong: This is an observational study, not a controlled trial, so results may be less definitive. The drug is already approved, but real-world effectiveness can vary, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-invasive bladder urothelial carcinoma Non-Muscle Invasive Bladder Neoplasms superficial urinary bladder carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-MUSCLE INVASIVE BLADDER NEOPLASMS

Contacts and locations

Locations

Arkansas Urology
RECRUITING

Little Rock, Arkansas, 72211, United States
Associated Urological Specialists
RECRUITING

Chicago Ridge, Illinois, 60415, United States
Cedars Sinai Medical Center
RECRUITING

Los Angeles, California, 90048, United States
Colorado Clinical Research
RECRUITING

Lakewood, Colorado, 80228, United States
Florida Urology Partners
RECRUITING

Wimauma, Florida, 33598, United States
Indiana University Melvin and Bren Simon Cancer Center
RECRUITING

Indianapolis, Indiana, 46202, United States
Low Country Urology Clinics
RECRUITING

North Charleston, South Carolina, 29406, United States
Michigan Institute of Urology
RECRUITING

Troy, Michigan, 48084, United States
SUNY Upstate Med Univ
RECRUITING

Syracuse, New York, 13210, United States
Specialty Clinical Research of St Louis
RECRUITING

St Louis, Missouri, 63141, United States
Spokane Urology
RECRUITING

Spokane, Washington, 99202, United States
UPNT Research Institute
RECRUITING

Arlington, Texas, 76017, United States
USC Norris Comprehensive Cancer Center
RECRUITING

Los Angeles, California, 90033, United States
University of Alabama at Birmingham
RECRUITING

Birmingham, Alabama, 35294, United States
Urology Specialists of South Dakota
RECRUITING

Sioux Falls, South Dakota, 57108, United States
Urology Specialists of the Carolinas PLLC Charlotte
RECRUITING

Charlotte, North Carolina, 28204, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.